Landos Biopharma, Inc.

CIK 1785345 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Landos Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Jun 3, 202415-12G0001193125-24-152289
May 23, 202440001415889-24-014334
May 23, 202425-NSE0001354457-24-000356
May 23, 202440001415889-24-014342
May 23, 202440001415889-24-014337
May 23, 2024S-8 POS0001193125-24-146059
May 23, 202440001415889-24-014338
May 23, 20248-K0001193125-24-146014
May 23, 202440001415889-24-014340
May 23, 2024S-8 POS0001193125-24-146054
May 23, 2024S-8 POS0001193125-24-146048
May 23, 20248-K0001193125-24-145685
May 23, 202440001415889-24-014341
May 23, 2024RW0001193125-24-146069
May 23, 202440001415889-24-014335
May 23, 2024S-8 POS0001193125-24-146051
May 23, 202440001415889-24-014336
May 9, 202410-Q0000950170-24-056311
Apr 25, 2024DEFM14A0001193125-24-114268
Apr 16, 202410-K/A0001193125-24-097023
Apr 15, 2024PREM14A0001193125-24-096376
Apr 10, 2024SC 13D/A0001193125-24-091996
Apr 10, 2024SC 13D/A0001193125-24-091998
Mar 26, 2024DEFA14A0001193125-24-077190
Mar 25, 2024DEFA14A0001193125-24-076061